Amalfi to Washington D. C.

Thromb Haemost 2005; 93(04): 625-626
DOI: 10.1160/TH05-02-0110

Theme Issue Editorial Focus

Schattauer GmbH

Twenty years of plasminogen activator research

Toni M. Antalis

³Department of Physiology, University of Maryland School of Medicine, Rockville, Maryland, USA

,

Thomas H. Bugge

¹Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA

,

Daniel A. Lawrence

²Departments of Surgery and Physiology, University of Maryland School of Medicine, Rockville, Maryland, USA

,

Sarah Netzel-Arnett

³Department of Physiology, University of Maryland School of Medicine, Rockville, Maryland, USA

,

Bradford S. Schwartz

⁴Departments of Biochemistry and Medicine, University of Illinois College of Medicine, Urbana, Illinois, USA

,

Dudley K. Strickland

²Departments of Surgery and Physiology, University of Maryland School of Medicine, Rockville, Maryland, USA

References
1 Collen D, Lijnen R. Thrombolytic agents. Thromb Haemost 2005; 93: 627-30.
2 Dellas C, Loskutoff DJ. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005; 93: 631-40.
3 Mazzieri R, Blasi F. The urokinase receptor and the regulation of cell proliferation. Thromb Haemost 2005; 93: 641-6.
4 Castellino FJ, Polpis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost 2005; 93: 647-54.
5 Melchor JP, Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 2005; 93: 655-60.
6 Nagamine Y, Muñoz-Cánoves P, Medcalf RL. Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb Haemost 2005; 93: 661-75.
7 Danø K, Behrendt N, Høyer-Hansen G. et.al. Plasminogen activation and cancer. Thromb Haemost 2005; 93: 676-81.